Financials

  • Market Capitalization 328.1314 M
  • Employee 49
  • Founded 1995
  • CEO Diem Nguyen
  • Website www.siga.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKXWV1
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
19.09
Rapporto prezzo/fatturato
4.64
Dividendi per azione
0.6
Rendimento da dividendi %
9.82

SIGA Technologies Inc

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

Notizie